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OBJECTIVES We examined whether nicorandil, a clinically useful drug for the treatment of ischemic
syndromes, inhibits myocardial apoptosis.
BACKGROUND Nicorandil has been reported to have a cardioprotective action through activation of
mitochondrial ATP-sensitive potassium (mitoKATP) channels. Based on our recent obser-
vation that mitoKATP channel activation has a remarkable antiapoptotic effect in cultured
cardiac cells, we hypothesized that the protective effects of nicorandil may be at least partially
due to an antiapoptotic effect.
METHODS Cultured neonatal rat cardiac myocytes were exposed to hydrogen peroxide to induce
apoptosis. Effects of nicorandil were evaluated using a number of apoptotic markers.
RESULTS Exposure to 100 M hydrogen peroxide resulted in apoptotic cell death as shown by TUNEL
positivity, cytochrome c translocation, caspase-3 activation and dissipation of mitochondrial
inner membrane potential (m). Nicorandil (100 M) suppressed all of these markers of
apoptosis. Notably, nicorandil prevented m depolarization in a concentration-dependent
manner (EC50  40 M, with saturation by 100 M), as shown by fluorescence-activated
cell sorter analysis of cells stained with a fluorescent m-indicator, tetramethylrhodamine
ethyl ester (TMRE). Time-lapse confocal microscopy of individual cells loaded with TMRE
shows that nicorandil suppresses m loss. Subcellular calcein localization revealed inhibition
of the mitochondrial permeability transition by nicorandil. These protective effects of
nicorandil were blocked by the mitoKATP channel antagonist 5-hydroxydecanoate.
CONCLUSIONS Our findings identify nicorandil as an inhibitor of apoptosis induced by oxidative stress in
cardiac myocytes, and confirm the critical role of mitoKATP channels in inhibiting
apoptosis. (J Am Coll Cardiol 2002;40:803–10) © 2002 by the American College of
Cardiology Foundation
Nicorandil is a drug with both nitrate-like and ATP-
sensitive potassium (KATP) channel activating properties (1)
and is currently used clinically for the treatment of ischemic
heart disease. By virtue of this dual mechanism of action,
the drug acts as a balanced coronary and peripheral vasodi-
lator, reducing both preload and afterload. This drug has
been reported to have an infarct size limiting effect in a
number of studies that use animal models of ischemia/
reperfusion (2–4). In agreement with these findings, clinical
studies have documented beneficial effects of nicorandil in
patients undergoing angioplasty (5) as well as cardiopulmo-
nary bypass surgery (6). Moreover, adjunctive administra-
tion of nicorandil in patients with acute myocardial infarc-
tion resulted in better functional and clinical outcome (7,8).
The cardioprotective effects of nicorandil are at least par-
tially mediated by selective activation of KATP channels in
the mitochondrial inner membrane (mitoKATP channels)
(9,10).
We have recently found that activation of mitoKATP
channels inhibits oxidative stress-induced cellular apoptosis
in cultured neonatal rat cardiac myocytes, suggesting a
direct mechanistic link between mitoKATP channels and
programmed cell death (11). Since apoptosis substantially
contributes to cellular demise and subsequent functional loss
in a number of cardiovascular diseases (12), we conjectured
that the cardioprotective effects of nicorandil may be, at least
in part, attributable to an antiapoptotic effect. Here, we
demonstrate that nicorandil prevents apoptosis induced by
oxidative stress in isolated neonatal rat cardiac myocytes,
providing mechanistic insights of cardioprotection afforded
by nicorandil.
METHODS
All procedures were performed in accordance with the Johns
Hopkins University animal care guidelines, which conform
to the Guide for the Care and Use of Laboratory Animals,
published by the National Institute of Health.
Primary culture of neonatal rat cardiac myocytes. Car-
diac ventricular myocytes were prepared from 1 to 2-day-old
Sprague-Dawley rats and cultured as described (11). In
brief, the hearts were removed, and the ventricles were
minced into small fragments, which were digested by
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trypsin dissociation. The dissociated cells were preplated for
1 h to enrich the culture with myocytes. The nonadherent
myocytes were then plated in plating medium consisting of
Dulbecco’s Modified Eagle Medium (Mediatech) supple-
mented with 5% fetal bovine serum, penicillin (100 U/ml),
streptomycin (100 mg/ml), and 2 g/ml vitamin B12. The
final myocyte cultures contained 90% cardiac myocytes at
partial confluence. The cells were maintained at 37°C in the
presence of 5% CO2 in a humidified incubator. Bromode-
oxyuridine (0.1 mM) was included in the medium for the
first 3 days after plating to inhibit fibroblast growth.
Cultures were then placed in serum-free DMEM contain-
ing vitamin B12, transferrin and insulin, 24 h prior to the
drug treatment.
Experimental protocol. Neonatal rat cardiac myocytes in
primary culture were randomly assigned to one of four
experimental groups: 1) control group; 2) incubation with
100 M hydrogen peroxide (H2O2); 3) pretreatment with
100 M nicorandil for 20 min, followed by 100 M H2O2;
4) pretreatment with 100 M nicorandil and 500 M of
mitoKATP channel blocker, 5-hydroxydecanoate (5-HD)
for 20 min, followed by 100 M H2O2. At the beginning of
the experiment, culture media were replaced with fresh
serum-free DMEM containing those drugs, and cells were
exposed to those drugs during the entire experimental
period. Nicorandil is a gift from Chugai Pharmaceutical Co.
Ltd. (Tokyo, Japan).
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) staining. The TUNEL
staining was performed according to the manufacturer’s
protocol (Roche, Indianapolis, Indiana). Fluorescein labels
incorporated in nucleotide polymers were detected by laser
scanning confocal microscopy at an excitation wavelength of
488 nm (argon laser).
Immunofluorescence staining. Immunofluorescence
staining was carried out as described previously (11). In
brief, cells were plated on multiwell culture slides, treated
with drugs as indicated, fixed in an ice-cold 1:1 mixture of
methanol/acetone, blocked with 10% normal goat serum
and 0.075% saponin in PBS, and incubated with primary
antibody dissolved in blocking solution at a dilution of
1:100. For cytochrome c staining, mouse monoclonal anti-
cytochrome c antibody (Pharmingen; 6H2.Ba4) was used;
for caspase-3 staining, rabbit polyclonal antiserum raised
against the activated form of caspase-3 (Pharmingen),
which recognizes only the processed 20 kDa subunit of
cleaved caspase-3, was used. After washing with PBS, cells
were incubated with secondary antibody consisting of Alexa
Fluor 546 goat antimouse IgG, F(ab)2 (Molecular Probes,
diluted 1:100) or Alexa Fluor 546 goat anti-rabbit IgG,
F(ab)2 (Molecular Probes, diluted 1:100, Eugene, Oregon)
respectively. Finally, cells were counterstained with the
DNA binding dye DAPI (5 M, Molecular Probes). Cells
were examined by a laser scanning confocal microscope
(Zeiss, LSM 410, Thornwood, New York), using 40
water-immersion lens and 2 optical zoom. Alexa 546 was
excited and visualized by a helium/neon laser (543 nm), and
DAPI by an ultraviolet laser (351 nm).
Caspase-3 activity assay. Caspase-3 activity was measured
by detection of the cleavage of a colorimetric caspase-3
substrate, N-acetyl-Asp-Glu-Val-Asp-p-nitroaniline, using
an assay kit, ApoAlert CPP32 (Clontech, Palo Alto, Cali-
fornia). The assay was performed according to the manu-
facturer’s protocol at 4, 8, and 16 h of stimulation by each
drug. In brief, lysates from cells were incubated in a reaction
mixture including N-acetyl-Asp-Glu-Val-Asp-p-nitroaniline
as a substrate of caspase-3-like proteases for 1 h at 37°C.
The levels of the resulting proteolytic fragment
p-nitroanilide were measured as optical density at 405 nm.
The relative activity was standardized by protein concentra-
tion, which was determined using Bradford protein assay
reagent (Bio-Rad, Hercules, California).
Assessment of mitochondrial membrane potential
(m). Loss of m was assessed using either
fluorescence-activated cell sorter (FACS) analysis or time-
lapse laser scanning confocal microscopy of cells stained
with tetramethylrhodamine ethyl ester (TMRE, Molecular
Probes) (13). Cells were incubated with 100 ng/ml TMRE
for at least 15 min in 37°C before starting drug treatment.
For FACS analysis, cells were harvested by trypsinization
at the end of experimental protocols, and analyzed by
FACScan (20,000 cells/sample). The fluorescence intensity
of TMRE was monitored at 582 nm (FL-2). The FACS
data were analyzed using analysis software (WinMDI,
http://facs/scripps.edu/software.html).
For time-lapse confocal analysis of m, cells plated on
35 mm dishes were maintained at 37°C using a heater
platform (Warner Instrument, Hamden, Connecticut) in-
stalled on a microscope stage, and were placed in phenol-
red-free DMEM (Life-Tech, Carlsbad, California) supple-
mented with 50 nM TMRE and 25 mM HEPES, in order
to avoid pH changes in the non–CO2-equilibrated environ-
ment. After the desired temperature was reached, time-
lapse confocal microscopy was started with a 5 min interval,
using 20 objective lens. The TMRE was excited using a
543 nm line of a helium/neon laser. Fifty cells were
randomly selected in each scan by drawing regions around
individual cells, and red fluorescence intensity was sequen-
tially monitored.
Abbreviations and Acronyms
m  mitochondrial inner membrane potential
5-HD  5-hydroxydecanoate
FACS  fluorescence-activated cell sorter
KATP  adenosine triphosphate-sensitive potassium
mitoKATP  mitochondrial adenosine triphosphate-
sensitive potassium
PTP  (mitochondrial) permeability transition pore
TMRE  tetramethylrhodamine ethyl ester
TUNEL  terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labeling
804 Akao et al. JACC Vol. 40, No. 4, 2002
Nicorandil as an Antiapoptotic Agent August 21, 2002:803–10
Assessment of mitochondrial permeability transition
pore (PTP). To monitor the opening of PTP, cultured
cardiac myocytes were loaded with calcein acetomethoxy
ester (calcein-AM) (Molecular Probes), as previously de-
scribed (14) with minor modifications. Briefly, cells loaded
with 100 nM of TMRE (37°C, 15 min), were further
loaded for 15 min with 2 M calcein-AM at room
temperature in the presence of 4 mM of cobalt chloride
(CoCl2) to quench cytosolic and nuclear calcein loading.
After washing calcein-AM and CoCl2, cells were kept at
37°C using a heater platform installed on a microscope
stage. Calcein was excited with 488 nm line of an argon
laser.
Statistical analysis. Statistical analysis of changes in
caspase-3 activity over the time course and that of the
percentage of cells with high TMRE fluorescence were
performed using one-way analysis of variance with Fisher’s
least significant difference as the post-hoc test. A level of p
 0.05 was accepted as statistically significant.
RESULTS
Figure 1A to 1D demonstrates TUNEL staining in each
experimental group. The TUNEL staining detects nuclear
DNA strand breaks, which occur during the terminal phase
of apoptosis. Control cells exhibited sparse TUNEL-
positive nuclei (Fig. 1A), but exposure to 100 M H2O2 for
16 h increased the number of TUNEL-positive nuclei,
which can be seen as bright spots (Fig. 1B), indicating
enhanced apoptosis under the treatment with H2O2. There
are obviously fewer TUNEL-positive nuclei in the
nicorandil-treated group (Fig. 1C), despite the similar
density of cells compared with H2O2 group. This protective
effect of nicorandil was blocked by the selective mitoKATP
channel antagonist 5-HD (Fig. 1D), suggesting that this
protective effect of nicorandil is mediated by mitoKATP
channel opening.
Figure 2A to 2D demonstrates cytochrome c immuno-
fluorescence. Cytochrome c, a member of the electron
transport chain, has been revealed to play a critical role in
the initiation of apoptosis; the translocation of cytochrome
c from mitochondria to the cytoplasm in response to a
variety of stress subsequently causes cleavage and activation
of the apoptosis-executioner proteases, caspases (15,16). As
shown in Figure 2A, the distribution of cytochrome c is
punctate, suggesting mitochondrial localization, which was
further confirmed with colocalization with a specific mito-
chondrial marker dye, MitoTracker (Molecular Probes)
(data not shown). Incubation with 100 M H2O2 for 16 h
induced cytochrome c translocation to the cytoplasm, result-
ing in a homogeneous distribution (Fig. 2B). Pretreatment
with nicorandil inhibited the translocation of cytochrome c
(Fig. 2C), while the addition of 500 M 5-HD cancelled
the effect of nicorandil (Fig. 2D).
Figure 3A to 3D demonstrates the immunofluorescent
staining for caspase-3, another key contributor to the
execution of apoptosis (17). In this experiment, polyclonal
antiserum that recognizes only the active form of the
enzyme was used. Therefore, cells that have activated
caspase-3 are recognized by the antibody and stained as red.
Figure 1. The TUNEL staining in neonatal rat cardiac myocytes. (A)
Control cells. (B) Cells exposed to 100 M H2O2 for 16 h. (C) Cells
pretreated with 100 M nicorandil followed by 100 M H2O2 for 16 h.
(D) Cells pretreated with 100 M nicorandil and 500 M
5-hydroxydecanoate, followed by 100 M H2O2 for 16 h.
Figure 2. Immunofluorescent staining for cytochrome c in neonatal rat
cardiac myocytes. Blue fluorescent dye DAPI demonstrates the nuclear
morphology. (A) Control cells. (B) Cells exposed to 100 M H2O2 for
16 h. (C) Cells pretreated with 100 M nicorandil followed by 100 M
H2O2 for 16 h. (D) Cells pretreated with 100 M nicorandil and 500 M
5-hydroxydecanoate, followed by 100 M H2O2 for 16 h. Each panel
contains an inset to demonstrate high power image.
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In control, cells showed little cytosolic fluorescence (Fig.
3A), but incubation with 100 M H2O2 for 16 h increased
the red signal in the cytosol (Fig. 3B). Pretreatment with
100 M nicorandil inhibited the H2O2-induced activation
of caspase-3 (Fig. 3C), while addition of 500 M 5-HD
abrogated the effect of nicorandil (Fig. 3D). Caspase-3
activity in each group was further quantified using colori-
metric caspase-3 substrate (Fig. 3E). Exposure to 100 M
H2O2 resulted in time-dependent increase in caspase-3
activity. Pretreatment with nicorandil significantly inhibited
caspase-3 activation at all time points.
Next, we measured m as an early apoptotic marker in
all experimental groups, using FACS analysis of cells
stained with a fluorescent m indicator, TMRE. This
cationic dye accumulates in mitochondria driven by the
negative mitochondrial matrix potential under the normal
conditions. Depolarization of m is represented by the
loss of TMRE fluorescence. Figure 4A shows histograms of
Figure 3. Immunofluorescent staining for active form of caspase-3 in neonatal rat cardiac myocytes. Red fluorescence represents 20-kDa active form of
caspase-3. Blue fluorescent dye DAPI demonstrates the nuclear morphology. (A) Control cells. (B) Cells exposed to 100 M H2O2 for 16 h. (C) Cells
pretreated with 100 M nicorandil followed by 100 M H2O2 for 16 h. (D) Cells pretreated with 100 M nicorandil and 500 M 5-hydroxydecanoate,
followed by 100 M H2O2 for 16 h. (E) Time-dependent changes in caspase-3 activity measured by detection of the cleavage of a colorimetric caspase-3
substrate. Each data point is expressed as a relative ratio against the control value of the same time points (n  3 for each data point). Control value in
each time point is defined as 100%. There are no actual data for 0 h. C  control (open circle); H  H2O2 100 M (closed square); NC  H2O2 	
nicorandil 100 M (open square). Data are mean 
 SEM. *p  0.05 vs. C or NC.
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TMRE fluorescence in the various experimental groups.
The majority of cells in the control group (Fig. 4A, panel C)
belonged to a population with high TMRE fluorescence
level (indicated by vertical dashed line). Exposure to H2O2
shifted the predominant population to lower TMRE fluo-
rescence (panel H). Nicorandil protected against H2O2-
induced loss of m, preserving a sizable population of cells
with a normal m level (panel NC). The protective effect
of diazoxide was abolished by 500 M 5-HD, shifting cells
into populations with low m level (panel 5HD). Similar
experiments were further carried out for various concentra-
tions of nicorandil, and the mean fluorescence intensities
from those histograms were obtained (Fig. 4B). This result
clearly shows the positive concentration-response relation-
ship of nicorandil. The m-preserving effect of nicorandil
saturates at 100 M and EC50 is 40 M. This value is
comparable to that known to activate mitoKATP channels
(10). In addition, 5-HD alone had no effect on m in the
absence of nicorandil and it did not promote any of the
apoptotic markers examined here compared with the control
group (data not shown), and its incubation together with
H2O2 did not further aggravate those markers compared
with the H2O2-treated drug-free group. Figure 4C summa-
rizes pooled data showing the percentage of cells, which
retain a high TMRE fluorescence (defined as 102 in this
analysis) in various experimental groups. These data indicate
that nicorandil is effective in limiting the extent of m
depolarization due to H2O2, and that the protection is
5-HD-sensitive.
To examine the time-dependent changes of m on a
single-cell basis, we used time-lapse confocal analysis of
cardiac myocytes loaded with TMRE. Images were taken
every 5 min over the entire time-course of 90 min. The
majority of cells underwent m changes within 90 min,
and there were no further changes of signals afterwards. In
Figure 5A to 5D, representative confocal images of cardiac
myocytes at selected time points are shown. Throughout the
period of observation (90 min), TMRE fluorescence inten-
Figure 4. Mitochondrial membrane potential (m) in neonatal rat cardiac myocytes assessed by fluorescence-activated cell sorter (FACS) analysis of cells
stained with a red fluorescent m indicator, tetramethylrhodamine ethyl ester (TMRE). (A) The histograms of FL-2 channel (red fluorescence) are
shown. C  control; H  100 M H2O2 for 2 h; NC  pretreatment with 100 M nicorandil followed by 100 M H2O2 for 2 h; 5HD  pretreatment
with 100 M nicorandil and 500 M 5-hydroxydecanoate, followed by 100 M H2O2 for 2 h. In all of the histograms the position of the major population
of control cells were indicated by vertical dashed line. Results are representative data from at least four independent experiments. (B) Mean values of
TMRE fluorescence obtained from FL-2 histograms of FACS analysis. Bars, from left to right, show data from the following: bar 1  H2O2; bar 2 
H2O2 	 nicorandil 20 M; bar 3  H2O2 	 nicorandil 50 M; bar 4  H2O2 	 nicorandil 100 M; bar 5  H2O2 	 nicorandil 200 M; bar 6 
H2O2 	 nicorandil 100 M 	 5-HD 500 M. The concentration of H2O2 was 100 M for all groups. The value of control group was 203. (C)
Summarized data of the percentage of cells that maintain high (102) TMRE fluorescence (n  4 for all groups). Data are mean 
 SEM. *p  0.05 vs.
C group. #p  0.05 vs. H group.
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sities of control cells remained unchanged (Fig. 5A). In
contrast, cells treated with 100 M H2O2 progressively lost
TMRE fluorescence, indicating irreversible dissipation of
m (Fig. 5B). Nicorandil remarkably inhibited this cata-
strophic loss of m, and the majority of cells maintained
intact m (Fig. 5C). This protective effect of nicorandil
was abrogated by 5-HD (Fig. 5D). From these image
sequences, 50 cells were randomly and prospectively selected
in each group, and the mean values of red fluorescence
intensity from each cell are plotted in Figure 5E to 5H.
Exposure to H2O2 caused catastrophic loss of m in most
of the cells (Fig. 5F). The duration of m loss of each cell
Figure 5. (A to D) Time-lapse analysis of the loss of mitochondrial inner membrane potential in neonatal rat cardiac myocytes. Cells were subjected to
time-scan for 90 min at 5-min interval. Images from selected time points are shown. (A) Control cells. (B) Cells exposed to 100 M H2O2. (C) Cells
pretreated with 100 M nicorandil followed by 100 M H2O2. (D) Cells pretreated with 100 M nicorandil and 500 M 5-hydroxydecanoate (5-HD),
followed by 100 M H2O2. (E to H) Time course of red fluorescence in each individual cell which was prospectively selected at the beginning of the scan
(E  control cells; F  H2O2 100 M; G  H2O2 100 M 	 nicorandil 100 M; H  H2O2 100 M 	 nicorandil 100 M 	 5-HD 500 M). All
of 50 cells are shown. (I) Confocal images of cardiac myocytes co-loaded with tetramethylrhodamine ethyl ester (TMRE) (red) and a fluorescent
mitochondrial permeability transition pore indicator, calcein (green). (Left panel) Cells exposed to 100 M H2O2 for 1 h. (Right panel) Cells pretreated
with 100 M nicorandil followed by 100 M H2O2 for 1 h.
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was abrupt (5 to 10 min) and complete, regardless of the
time elapsed since the H2O2 was applied. Nicorandil
decreased the number of cells undergoing m loss (Fig.
5G), and its protective effect was negated by 5-HD (Fig.
5H). However, nicorandil did not change the duration of
m loss in those cells that did lose their inner membrane
potential.
Such an abrupt and irreversible dissipation of m may
result from opening of PTP (18,19), a pathway which
contributes not only to apoptosis but also to necrosis
(20,21). Therefore, we investigated if the effects of nicoran-
dil on preservation of m are related to the inhibition of
PTP opening. Myocytes were co-loaded with TMRE and
the green fluorescent indicator calcein. Fluorescent calcein
concentrates in the mitochondrial matrix, such that the loss
of punctate calcein fluorescence can be used to detect the
opening of the PTP in situ (14). Exposure to H2O2 resulted
in loss of TMRE and concomitant massive translocation of
calcein fluorescence from the mitochondrial matrix into the
cytoplasm, indicating that the abrupt loss of m is
mediated by PTP opening (Fig. 5I, left panel). Pretreatment
with nicorandil effectively suppressed the PTP opening as
demonstrated by preserved TMRE fluorescence and main-
tained punctate localization of calcein in the mitochondria
(Fig. 5I, right panel).
DISCUSSION
Nicorandil as a cardioprotective agent. Nicorandil has
attracted keen interest due to its well-documented cardio-
protective actions both in vivo and in vitro. A number of
studies in animal models of ischemia/reperfusion indicate
that nicorandil has cardioprotective effects, as evidenced by
the preservation of cardiac function or infarct size reduction
(2–4). Meanwhile, studies in patients undergoing percuta-
neous transluminal coronary angioplasty have shown that
the administration of nicorandil reduces ST-segment eleva-
tion during ischemia (5). Similar beneficial effects of nic-
orandil in patients undergoing coronary bypass surgery have
been described as well (6). The drug also improved the
results of exercise tolerance tests relative to placebo in early
randomized, double blind, placebo-controlled trials (22). In
randomized, double-blind comparative studies in patients
with angina pectoris, nicorandil has demonstrated equiva-
lent efficacy, as measured by exercise tolerance testing, to
isosorbide dinitrate and mononitrate, metoprolol, propran-
olol, atenolol, diltiazem, amlodipine and nifedipine (23,24).
Moreover, adjunctive administration of nicorandil can im-
prove regional left ventricular wall motion in patients with
acute myocardial infarction, and result in better clinical
outcomes as assessed by the incidence of malignant arrhyth-
mia or congestive heart failure (7,8).
We have previously reported that the mitoKATP opening
plays a major role in cardioprotection afforded by nicorandil
(10). We and other investigators have suggested a paradigm
whereby activation of mitoKATP channels is a significant
mechanism of preconditioning-associated cytoprotection
(9,25). Diazoxide, the archetypical agonist of mitoKATP
channels, has recently been found to suppress apoptosis
(11). Thus, there is good reason to wonder whether nic-
orandil may likewise function as an inhibition of apoptosis,
a property, which might rationalize its cardioprotective
effects.
More recently, large-scale randomized clinical trial has
been started to test the effects of nicorandil on the incidence
of cardiovascular events in patients with chronic effort
angina (Impact of Nicorandil in Angina: IONA study) (26).
This study is currently underway, but preliminary data
presented at the American Heart Association Scientific
Sessions in 2001 demonstrated that nicorandil was associ-
ated with a significant risk reduction in coronary heart
disease death, non–fatal myocardial infarction and un-
planned hospitalization. Despite those remarkable effects
against coronary heart disease and widespread use of the
drug in Japan and Europe, nicorandil is not presently
available in the U.S. As a result of this clinical trial as well
as a number of experimental studies including ours, the
status of this drug in the U.S. might have to be reconsid-
ered.
MitoKATP channels and apoptosis. Apoptosis is a tightly
regulated mode of cell death, which has been revealed to
play a role in the pathogenesis of a number of human
diseases. It accounts for at least part of cell death or
functional organ failure in acute myocardial infarction or
congestive heart failure (12). We have discovered that the
activation of mitoKATP channels inhibits oxidative stress-
induced apoptosis in isolated cardiac myocytes (11). Unfor-
tunately, the precise molecular mechanisms by which mi-
toKATP channel opening protects against apoptosis remain
elusive. However, as evidenced in this and our previous
study (11), mitoKATP acting drugs not only suppress nuclear
breakdown, which is a terminal phenotype in the entire
apoptosis pathway, but also inhibit early apoptotic events,
such as cytochrome c release or m depolarization. The
way nicorandil inhibits m loss resembles that of diazox-
ide (11); nicorandil not only decreased the number of cells
undergoing dissipation of m, but also delayed the onset
of m loss, whereas it did not change the duration of m
loss in the minority of cells that were not protected. These
observations suggest that nicorandil could modulate the
initiation process of m loss, but not the dissipating
process itself.
We have more recently found that the activation of
mitoKATP channels prevented calcium overload in mito-
chondrial matrix induced by metabolic inhibition (27).
Mitochondrial matrix calcium overload is a well-
documented trigger of PTP (28). Therefore, the prevention
of PTP might be a functional consequence of mitoKATP
channel activation. Supporting this hypothesis, we demon-
strated that nicorandil prevented the opening of PTP
induced by H2O2 using a fluorescent PTP indicator, calcein
(Fig. 5I). The prevention of PTP may be a critical mecha-
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nism by which mitoKATP channel opening elicits preserva-
tion of mitochondrial integrity and consequent protection of
cellular function.
Clinical implications. Apoptotic cell death is observed in
pathological situations of the heart such as acute myocardial
infarction (29) or congestive heart failure (30). Since cardiac
myocytes are terminally differentiated and are refractory to
cell cycle entry, apoptotic cell death in the myocardium
likely result in a cumulative decrease in cell number and
progressive functional loss (12). Therefore, understanding
how cardiac myocytes undergo apoptosis under a variety of
cellular stress is of primary importance for developing
rational therapeutic strategies that may prevent myocyte
death after injury or disease. In this study, we demonstrate
the antiapoptotic property of a clinically used antianginal
drug, nicorandil. Recognition of nicorandil’s antiapoptotic
effect suggests that this agent may have potential clinical
benefit not only in ischemic syndromes, but also in the
broad category of cardiovascular diseases in which apoptosis
is involved.
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